✦ LIBER ✦

Neuroprotection of Maslinic Acid, a Novel Glycogen Phosphorylase Inhibitor, in Type 2 Diabetic Rats

✍ Scribed by Teng GUAN; Yi-Song QIAN; Meng-Hao HUANG; Long-Fei HUANG; Xu-Zhen TANG; Yun-Man LI; Hong-Bin SUN

Book ID: 119639307
Publisher: Elsevier
Year: 2010
Tongue: Chinese
Weight: 347 KB
Volume: 8
Category: Article
ISSN: 1875-5364
DOI: 10.1016/s1875-5364(10)60037-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of Maslinic Acid as a Novel Glyc

Effects of Maslinic Acid as a Novel Glycogen Phosphorylase Inhibitor on Blood Glucose and Hepatic Glycogen in Mice

✍ Xu-Zhen TANG; Teng GUAN; Yi-Song QIAN; Yun-Man LI; Hong-Bin SUN; Jing-Hui HUANG; 📂 Article 📅 2008 🏛 Elsevier 🌐 Chinese ⚖ 168 KB

Maslinic acid, a natural inhibitor of gl

Maslinic acid, a natural inhibitor of glycogen phosphorylase, reduces cerebral ischemic injury in hyperglycemic rats by GLT-1 up-regulation

✍ Teng Guan; Yisong Qian; Xuzhen Tang; Menghao Huang; Longfei Huang; Yunman Li; Ho 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 710 KB

## Abstract Maslinic acid (MA), a natural triterpene from __Olea europaea__ L., is a well‐known inhibitor of glycogen phosphorylase and elicits multiple biological activities. The purpose of this study was to evaluate the effects of MA on focal cerebral ischemia in hyperglycemic rats. Adult rats we

FR258900, a Novel Glycogen Phosphorylase

FR258900, a Novel Glycogen Phosphorylase Inhibitor Isolated from Fungus No.138354. Part 2. Antihyperglycemic Effects in Diabetic Animal Models.

✍ Shigetada Furukawa; Kana Murakami; Motoaki Nishikawa; Osamu Nakayama; Motohiro H 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 8 KB 👁 1 views

Effects of ferulic acid on diabetic neph

Effects of ferulic acid on diabetic nephropathy in a rat model of type 2 diabetes

✍ Choi, Ran; Kim, Bo Hwan; Naowaboot, Jarinyaporn; Lee, Mi Young; Hyun, Mi Ri; Cho 📂 Article 📅 2011 🏛 Korean Society of Medical Biochemistry and Molecul 🌐 English ⚖ 583 KB

Empagliflozin, a novel potent and select

Empagliflozin, a novel potent and selective SGLT-2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin-induced diabetic rats, a model of type 1 diabetes mellitus

✍ G. Luippold; T. Klein; M. Mark; R. Grempler 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 701 KB

Chronic feeding of a nitric oxide syntha

Chronic feeding of a nitric oxide synthase inhibitor induces postprandial hypertriglyceridemia in type 2 diabetic model rats, Otsuka Long-Evans Tokushima Fatty rats, but not in nondiabetic rats

✍ Yutaka Nakaya; Noriko Ishimura; Eiko Takishita; Akira Takahashi 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 124 KB